Capital Flow Monitor · Sponsors · CIK 1795076
Deinde Medical Corp.
10370 USA TODAY WAY, MIRAMAR, FL, 33025 · 305-753-6511
Other Health Care · Corporation· inc. DELAWARE true
Fit score
—
Offering
$2.0M
Sold
$185K
% sold
9.3%
Investors
3
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-11-12 | D ·current | 506(b) | $2.0M | $185K | 9.3% | 3 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Marc Litzenberg — Executive Officer / Director, MIRAMAR, FL
1 other raise
- NeuroFine Corp. $1.0M of $1.0M · 100.0%
-
Bernie Navarro — Executive Officer, MIRAMAR, FL
2 other raises
- Prometheus Therapeutics Inc. $2.7M of $6.5M · 42.2%
- NeuroFine Corp. $1.0M of $1.0M · 100.0%
-
Prattipati Laxminarain — Director, MIRAMAR, FL
2 other raises
- GT MEDICAL TECHNOLOGIES, INC. $50.1M of $100.1M · 50.0%
- Microbot Medical Inc. $25.2M of $25.2M · 100.0%
-
Ajay Wakhloo — Director, MIRAMAR, FL
2 other raises
- Prometheus Therapeutics Inc. $2.7M of $6.5M · 42.2%
- NeuroFine Corp. $1.0M of $1.0M · 100.0%
-
John McEleney — Director, MIRAMAR, FL
3 other raises
- Verve, Inc. $12.8M of $16.4M · 77.7%
- Prometheus Therapeutics Inc. $2.7M of $6.5M · 42.2%
- NeuroFine Corp. $1.0M of $1.0M · 100.0%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.